These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7507992)

  • 1. Potassium channel inhibitors attenuate neuromodulatory effects of atrial natriuretic factor in the rabbit isolated vas deferens.
    Kanwal S; Trachte GJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):117-23. PubMed ID: 7507992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
    Winquist RJ; Heaney LA; Wallace AA; Baskin EP; Stein RB; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1989 Jan; 248(1):149-56. PubMed ID: 2464055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of adrenergic responses of human vas deferens by K+ channel inhibitors.
    Medina P; Segarra G; Mauricio MD; Vila JM; Chuan P; Lluch S
    Urology; 2010 Dec; 76(6):1518.e7-12. PubMed ID: 20932556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
    Drewett JG; Trachte GJ; Marchand GR
    J Pharmacol Exp Ther; 1989 Jan; 248(1):135-42. PubMed ID: 2536425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of K+ channel blockers and cromakalim (BRL 34915) on the mechanical activity of guinea pig detrusor smooth muscle.
    Grant TL; Zuzack JS
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1158-64. PubMed ID: 1722252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prejunctional actions of K+ channel blockers in rat vas deferens.
    Docherty JR; Brady G
    Eur J Pharmacol; 1995 Dec; 287(3):287-93. PubMed ID: 8991803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyburide-sensitive K+ channels in cultured rat hippocampal neurons: activation by cromakalim and energy-depleting conditions.
    Politi DM; Rogawski MA
    Mol Pharmacol; 1991 Aug; 40(2):308-15. PubMed ID: 1715018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-sensitive K+ channels from aortic smooth muscle incorporated into planar lipid bilayers.
    Kovacs RJ; Nelson MT
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H604-9. PubMed ID: 1715132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
    Trachte GJ
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Ca(2+)-activated K(+) channels and Na(+),K(+)-ATPase in prostaglandin E(1)- and E(2)-induced inhibition of the adrenergic response in human vas deferens.
    Medina P; Segarra G; Mauricio MD; Vila JM; Chuan P; Lluch S
    Biochem Pharmacol; 2011 Jul; 82(1):65-71. PubMed ID: 21458424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive antagonism by glibenclamide of cromakalim inhibition of twitch contractions in rabbit vas deferens.
    Eltze M
    Eur J Pharmacol; 1989 Feb; 161(1):103-6. PubMed ID: 2470594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ release from isolated sarcoplasmic reticulum of guinea-pig psoas muscle induced by K(+)-channel blockers.
    Ishida Y; Honda H; Watanabe TX
    Br J Pharmacol; 1992 Aug; 106(4):764-5. PubMed ID: 1382785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in rabbit isolated vasa deferentia.
    Johnson BG; Trachte GJ; Drewett JG
    J Pharmacol Exp Ther; 1991 May; 257(2):720-6. PubMed ID: 1851836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cromakalim blocks the purinergic response evoked in rat vas deferens by single-pulse electrical stimulation.
    Grana E; Boselli C; Bianchi L
    Eur J Pharmacol; 1997 Jan; 319(1):57-64. PubMed ID: 9030898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of potassium channel modulators cromakalim, tetraethylammonium and glibenclamide on the contractility of the isolated human ureter.
    de Moura RS; de Lemos Neto M
    J Urol; 1996 Jul; 156(1):276-80. PubMed ID: 8648822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery.
    Eckman DM; Frankovich JD; Keef KD
    Br J Pharmacol; 1992 May; 106(1):9-16. PubMed ID: 1504734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by glibenclamide of the effects of cromakalim on responses of rat vas deferens to naphazoline.
    Grana E; Barbieri A; Zonta F
    Eur J Pharmacol; 1991 Sep; 202(1):93-6. PubMed ID: 1786804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta.
    Hutcheson IR; Griffith TM
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H590-6. PubMed ID: 7511348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of pinacidil, cromakalim, and NS 1619 on electrically evoked contractions in rat vas deferens.
    Huang Y; Lau CW
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):293-8. PubMed ID: 10072907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BaCl2- and 4-aminopyridine-evoked phasic contractions in the rat vas deferens.
    Huang Y
    Br J Pharmacol; 1995 Jul; 115(5):845-51. PubMed ID: 8548186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.